Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Hazzan

Showing results (21-30 of 120) with videos related to

Pageof 12
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2010
NK cell regulation of CD4 T cell-mediated graft-versus-host diseaseMagali Noval Rivas, Marc Hazzan, Kathleen Weatherly, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 24, 2019
Transplant center characteristics associated with living-donor kidney transplantation: a cohort study with a hierarchical modeling approachValérie Châtelet, Philippe Gatault, Marc Hazzan, et al.
Fundamental & Clinical Pharmacology|October 26, 2017
Factors associated with the variability of calcineurin inhibitor blood levels in kidney recipients grafted for more than 1 yearStéphanie Belaiche, Bertrand Décaudin, Sébastien Dharancy, et al.
European Journal of Clinical Investigation|June 14, 2020
A simple score to predict early death after kidney transplantationJamal Bamoulid, Marie Frimat, Cécile Courivaud, et al.
Epidemiology (Cambridge, Mass.)|December 7, 2020
Clinical Trial Emulation by Matching Time-dependent Propensity Scores: The Example of Estimating Impact of Kidney TransplantationRémi Lenain, Julie Boucquemont, Karen Leffondré, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 20, 2021
Association Between Deceased Donor Acute Kidney Injury Assessed Using Baseline Serum Creatinine Back-Estimation and Graft Survival: Results From the French National CRISTAL RegistryRémi Lenain, Camille Prouteau, Aghilès Hamroun, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|May 21, 2026
Cédric Annweiler, Marc Hazzan, T Moulin, et al.
Nephrologie & Therapeutique|February 26, 2018
[Clinical pharmacist and medication reconciliation in kidney transplantation]Fabienne Flamme-Obry, Stéphanie Belaiche, Marc Hazzan, et al.
Clinical Science (London, England : 1979)|August 24, 2002
HMG-CoA reductase inhibition and PPAR- alpha activation both inhibit cyclosporin A induced endothelin-1 secretion in cultured endothelial cellsAbdelmejid Kandoussi, François Martin, Marc Hazzan, et al.
La Revue De Medecine Interne|July 10, 2024
[The expert panel for Script Concordance Tests: A truly adequate reference?]Luc Dauchet, Raphaël Bentegeac, Haress Ghauss, et al.
Pageof 12

Showing results (21-30 of 120) with videos related to

Sort By:
Pageof 12
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2010
NK cell regulation of CD4 T cell-mediated graft-versus-host diseaseMagali Noval Rivas, Marc Hazzan, Kathleen Weatherly, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 24, 2019
Transplant center characteristics associated with living-donor kidney transplantation: a cohort study with a hierarchical modeling approachValérie Châtelet, Philippe Gatault, Marc Hazzan, et al.
Fundamental & Clinical Pharmacology|October 26, 2017
Factors associated with the variability of calcineurin inhibitor blood levels in kidney recipients grafted for more than 1 yearStéphanie Belaiche, Bertrand Décaudin, Sébastien Dharancy, et al.
European Journal of Clinical Investigation|June 14, 2020
A simple score to predict early death after kidney transplantationJamal Bamoulid, Marie Frimat, Cécile Courivaud, et al.
Epidemiology (Cambridge, Mass.)|December 7, 2020
Clinical Trial Emulation by Matching Time-dependent Propensity Scores: The Example of Estimating Impact of Kidney TransplantationRémi Lenain, Julie Boucquemont, Karen Leffondré, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 20, 2021
Association Between Deceased Donor Acute Kidney Injury Assessed Using Baseline Serum Creatinine Back-Estimation and Graft Survival: Results From the French National CRISTAL RegistryRémi Lenain, Camille Prouteau, Aghilès Hamroun, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|May 21, 2026
Cédric Annweiler, Marc Hazzan, T Moulin, et al.
Nephrologie & Therapeutique|February 26, 2018
[Clinical pharmacist and medication reconciliation in kidney transplantation]Fabienne Flamme-Obry, Stéphanie Belaiche, Marc Hazzan, et al.
Clinical Science (London, England : 1979)|August 24, 2002
HMG-CoA reductase inhibition and PPAR- alpha activation both inhibit cyclosporin A induced endothelin-1 secretion in cultured endothelial cellsAbdelmejid Kandoussi, François Martin, Marc Hazzan, et al.
La Revue De Medecine Interne|July 10, 2024
[The expert panel for Script Concordance Tests: A truly adequate reference?]Luc Dauchet, Raphaël Bentegeac, Haress Ghauss, et al.
Pageof 12